Scott Valastyan
- Cancer Research top 0.5%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 3
- Oncology top 2%
- Cancer Cells and Metastasis 2
- Peptidase Inhibition and Analysis 2
- Molecular Biology top 2%
- Circular RNAs in diseases 4
- RNA modifications and cancer 2
- Histone Deacetylase Inhibitors Research 2
- Immunology and Allergy top 5%
- Cell Biology top 5%
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Robert A. WeinbergFerenc ReinhardtElizabeth PanLi MaTamer T. ÖnderJennifer J. YoungJulie Teruya‐FeldsteinFrank Westermann
- Partner nations
- United StatesNetherlandsBelgium
In The Last Decade
Scott Valastyan
12 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 2.1k
- Oncology 1.5k
- Molecular Biology 2.8k
- Immunology and Allergy 177
- Cell Biology 416
Countries citing papers authored by Scott Valastyan
This map shows the geographic impact of Scott Valastyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Valastyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Valastyan more than expected).
Fields of papers citing papers by Scott Valastyan
This network shows the impact of papers produced by Scott Valastyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Valastyan. The network helps show where Scott Valastyan may publish in the future.
Co-authorship network
The 18 scholars most cited alongside Scott Valastyan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 1 | |
| 2 | Tumor Metastasis: Molecular Insights and Evolving Paradigmsbreakdown → | 2011 | 3030 |
| 3 | 2011 | 2 | |
| 4 | 2011 | 75 | |
| 5 | 2011 | 89 | |
| 6 | miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis | 2010 | 1 |
| 7 | 2010 | 102 | |
| 8 | 2010 | 7 | |
| 9 | miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasisbreakdown → | 2010 | 1108 |
| 10 | 2009 | 11 | |
| 11 | 2009 | 66 | |
| 12 | 2007 | 42 |
About Scott Valastyan
Scott Valastyan is a scholar working on Cancer Research, Biochemistry and Oncology, having authored 12 papers that have together received 4.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Cells and Metastasis (2 papers), RNA modifications and cancer (2 papers), Cancer Mechanisms and Therapy (2 papers), Peptidase Inhibition and Analysis (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (1.5k citations) and Molecular Biology (2.8k citations). Scott Valastyan has collaborated with scholars based in United States, Netherlands and Belgium. Frequent co-authors include Robert A. Weinberg, Ferenc Reinhardt, Elizabeth Pan, Li Ma, Tamer T. Önder, Jennifer J. Young, Julie Teruya‐Feldstein, Frank Westermann, Daniel Muth and Pieter Mestdagh. Their work appears in journals such as Frontiers in Bioscience-Elite, Cell Cycle, Genes & Development, Nature Cell Biology and RNA Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.